Literature DB >> 4189962

Thio-tepa chemotherapy for ovarian carcinoma. Influence of remission and toxicity on survival.

R C Wallach, B Kabakow, G Blinick, W Antopol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4189962

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy in advanced ovarian cancer.

Authors:  C J Rodenburg; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.

Authors:  B Hagen; F Walseth; R A Walstad; T Iversen; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

Authors:  A B Miller; D J Klaassen; D A Boyes; D J Dodds; A Gerulath; M E Kirk; M Levitt; J G Pearson; C Wall
Journal:  Can Med Assoc J       Date:  1980-09-06       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.